Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 7/2009

01.07.2009 | Guidelines

2009 EANM parathyroid guidelines

verfasst von: Elif Hindié, Ömer Ugur, David Fuster, Michael ODoherty, Gaia Grassetto, Pablo Ureña, Andrew Kettle, Seza A. Gulec, Francesca Pons, Domenico Rubello

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 7/2009

Einloggen, um Zugang zu erhalten

Abstract

The present guidelines were issued by the Parathyroid Task Group of the European Association of Nuclear Medicine. The main focus was imaging of primary hyperparathyroidism. Dual-tracer and single-tracer parathyroid scintigraphy protocols were discussed as well as the various modalities of image acquisition. Primary hyperparathyroidism is an endocrine disorder with high prevalence, typically caused by a solitary parathyroid adenoma, less frequently (about 15%) by multiple parathyroid gland disease (MGD) and rarely (1%) by parathyroid carcinoma. Patients with MGD may have a double adenoma or hyperplasia of three or all four parathyroid glands. Conventional surgery has consisted in routine bilateral neck exploration. The current trend is toward minimally invasive surgery. In this new era, the success of targeted parathyroid surgery depends not only on an experienced surgeon, but also on a sensitive and accurate imaging technique. Recognizing MGD is the major challenge for pre-operative imaging, in order to not direct a patient towards inappropriate minimal surgery. Scintigraphy should also report on thyroid nodules that may cause confusion with a parathyroid adenoma or require concurrent surgical resection. The two main reasons for failed surgery are ectopic glands and undetected MGD. Imaging is mandatory before re-operation, and scintigraphy results should be confirmed with a second imaging technique (usually US for a neck focus, CT or MRI for a mediastinal focus). Hybrid SPECT/CT instruments should be most helpful in this setting. SPECT/CT has a major role for obtaining anatomical details on ectopic foci. However, its use as a routine procedure before target surgery is still investigational. Preliminary data suggest that SPECT/CT has lower sensitivity in the neck area compared to pinhole imaging. Additional radiation to the patient should also be considered. The guidelines also discuss aspects related to radio-guided surgery of hyperparathyroidism and imaging of chronic kidney disease patients with secondary hyperparathyroidism.
Literatur
1.
Zurück zum Zitat Elgazzar A, editor. “” from The pathophysiologic basis of nuclear medicine. Berlin, Springer; 2001. Chap. 7, Parathyroid gland. p. 141–46. Elgazzar A, editor. “” from The pathophysiologic basis of nuclear medicine. Berlin, Springer; 2001. Chap. 7, Parathyroid gland. p. 141–46.
2.
Zurück zum Zitat Giordano A, Rubello D. Le Paratiroidi - sez. endocrinologia. In: Dondi M, Giubbini R: Medicina nucleare nella pratica clinica. Bologna: Patron ed.; 2003. p.171–83. Giordano A, Rubello D. Le Paratiroidi - sez. endocrinologia. In: Dondi M, Giubbini R: Medicina nucleare nella pratica clinica. Bologna: Patron ed.; 2003. p.171–83.
4.
Zurück zum Zitat Mariani G, Gulec SA, Rubello D, Boni G, Puccini M, Pelizzo MR, et al. Preoperative localization and radioguided parathyroid surgery. J Nucl Med 2003;44:1443–58.PubMed Mariani G, Gulec SA, Rubello D, Boni G, Puccini M, Pelizzo MR, et al. Preoperative localization and radioguided parathyroid surgery. J Nucl Med 2003;44:1443–58.PubMed
5.
Zurück zum Zitat Guyton A. Ormone paratiroideo. Calcitonina. Metabolismo del calico e del fosforo. Vitamina D. Osso e denti. from Trattato di fisiologia medica. Piccin ed. 1995, Chap. 79, p. 948–66. Guyton A. Ormone paratiroideo. Calcitonina. Metabolismo del calico e del fosforo. Vitamina D. Osso e denti. from Trattato di fisiologia medica. Piccin ed. 1995, Chap. 79, p. 948–66.
6.
Zurück zum Zitat Bilezikian JP, Khan AA, Potts JT Jr., Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 2009;94:335–9. doi:10.1210/jc.2008-1763.PubMedCrossRef Bilezikian JP, Khan AA, Potts JT Jr., Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 2009;94:335–9. doi:10.​1210/​jc.​2008-1763.PubMedCrossRef
7.
Zurück zum Zitat DeLellis RA, Mazzaglia P, Mangray S. Primary hyperparathyroidism: a current perspective. Arch Pathol Lab Med 2008;132(8):1251–62.PubMed DeLellis RA, Mazzaglia P, Mangray S. Primary hyperparathyroidism: a current perspective. Arch Pathol Lab Med 2008;132(8):1251–62.PubMed
10.
Zurück zum Zitat Bozkurt MF, Uğur O, Hamaloğlu E, Sayek I, Gulec SA. Optimization of the gamma probe-guided parathyroidectomy. Am Surg 2003;69:720–5.PubMed Bozkurt MF, Uğur O, Hamaloğlu E, Sayek I, Gulec SA. Optimization of the gamma probe-guided parathyroidectomy. Am Surg 2003;69:720–5.PubMed
11.
Zurück zum Zitat Loney EL, Dick EA, Francis IS, Buscombe JR. Localization of parathyroid nodules. Radiology 2001;218:916–7.PubMed Loney EL, Dick EA, Francis IS, Buscombe JR. Localization of parathyroid nodules. Radiology 2001;218:916–7.PubMed
12.
Zurück zum Zitat De Feo ML, Colagrande S, Biagini C, Tonarelli A, Bisi G, Vaggelli L, et al. Parathyroid glands: combination of (99 m)Tc MIBI scintigraphy and US for demonstration of parathyroid glands and nodules. Radiology 2000;214:393–402.PubMed De Feo ML, Colagrande S, Biagini C, Tonarelli A, Bisi G, Vaggelli L, et al. Parathyroid glands: combination of (99 m)Tc MIBI scintigraphy and US for demonstration of parathyroid glands and nodules. Radiology 2000;214:393–402.PubMed
13.
Zurück zum Zitat Tomasella G. Diagnostic imaging in primary hyperparathyroidism. Radiological techniques: US-CAT-MR [in Italian]. Minerva Endocrinol 2001;26:3–12.PubMed Tomasella G. Diagnostic imaging in primary hyperparathyroidism. Radiological techniques: US-CAT-MR [in Italian]. Minerva Endocrinol 2001;26:3–12.PubMed
14.
Zurück zum Zitat Beierwaltes WH. Endocrine imaging: parathyroid, adrenal cortex and medulla, and other endocrine tumors. Part II. J Nucl Med 1991;32:1627–39.PubMed Beierwaltes WH. Endocrine imaging: parathyroid, adrenal cortex and medulla, and other endocrine tumors. Part II. J Nucl Med 1991;32:1627–39.PubMed
15.
Zurück zum Zitat Delbeke D, Coleman RE, Guiberteau MJ, Brown ML, Royal HD, Siegel BA, et al. Procedure Guideline for SPECT/CT Imaging 1.0. J Nucl Med 2006;47:1227–34.PubMed Delbeke D, Coleman RE, Guiberteau MJ, Brown ML, Royal HD, Siegel BA, et al. Procedure Guideline for SPECT/CT Imaging 1.0. J Nucl Med 2006;47:1227–34.PubMed
16.
Zurück zum Zitat Harris L, Yoo J, Driedger A, Fung K, Franklin J, Gray D, et al. Accuracy of technetium-99m SPECT-CT hybrid images in predicting the precise intraoperative anatomical location of parathyroid adenomas. Head Neck 2008;30:509–17. doi:10.1002/hed.20727.PubMedCrossRef Harris L, Yoo J, Driedger A, Fung K, Franklin J, Gray D, et al. Accuracy of technetium-99m SPECT-CT hybrid images in predicting the precise intraoperative anatomical location of parathyroid adenomas. Head Neck 2008;30:509–17. doi:10.​1002/​hed.​20727.PubMedCrossRef
17.
Zurück zum Zitat Lavely WC, Goetze S, Friedman KP, Leal JP, Zhang Z, Garret-Mayer E, et al. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m) Tc-sestamibi parathyroid scintigraphy. J Nucl Med 2007;48:1084–9. doi:10.2967/jnumed.107.040428.PubMedCrossRef Lavely WC, Goetze S, Friedman KP, Leal JP, Zhang Z, Garret-Mayer E, et al. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m) Tc-sestamibi parathyroid scintigraphy. J Nucl Med 2007;48:1084–9. doi:10.​2967/​jnumed.​107.​040428.PubMedCrossRef
19.
Zurück zum Zitat Gayed IW, Kim EE, Broussard WF, Evans D, Lee J, Broemeling LD, et al. The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia. J Nucl Med 2005;46:248–52.PubMed Gayed IW, Kim EE, Broussard WF, Evans D, Lee J, Broemeling LD, et al. The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia. J Nucl Med 2005;46:248–52.PubMed
21.
Zurück zum Zitat Ferlin G, Borsato N, Camerani M, Conte N, Zotti D. New perspectives in localizing enlarged parathyroids by technetium-thallium subtraction scan. J Nucl Med 1983;24:438–41.PubMed Ferlin G, Borsato N, Camerani M, Conte N, Zotti D. New perspectives in localizing enlarged parathyroids by technetium-thallium subtraction scan. J Nucl Med 1983;24:438–41.PubMed
22.
Zurück zum Zitat Coakley AJ, Kettle AG, Wells CP, O’Doherty MJ, Collins RE. 99Tcm sestamibi—a new agent for parathyroid imaging. Nucl Med Commun 1989;10:791–4.PubMedCrossRef Coakley AJ, Kettle AG, Wells CP, O’Doherty MJ, Collins RE. 99Tcm sestamibi—a new agent for parathyroid imaging. Nucl Med Commun 1989;10:791–4.PubMedCrossRef
23.
Zurück zum Zitat O’Doherty MJ, Kettle AG, Wells PC, Collins REC, Coakley AJ. Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studies. J Nucl Med 1992;33:313–8.PubMed O’Doherty MJ, Kettle AG, Wells PC, Collins REC, Coakley AJ. Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studies. J Nucl Med 1992;33:313–8.PubMed
24.
Zurück zum Zitat Fjeld JG, Erichsen K, Pfeffer PF, Clausen OP, Rootwelt K. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi. J Nucl Med 1997;38:831–4.PubMed Fjeld JG, Erichsen K, Pfeffer PF, Clausen OP, Rootwelt K. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi. J Nucl Med 1997;38:831–4.PubMed
25.
Zurück zum Zitat Sisson JC, Thompson NW, Ackerman RJ, Wahl RL. Use of 2-[F-18]-fluoro-2-deoxy-D-glucose PET to locate parathyroid adenomas in primary hyperparathyroidism. Radiology 1994;192:280.PubMed Sisson JC, Thompson NW, Ackerman RJ, Wahl RL. Use of 2-[F-18]-fluoro-2-deoxy-D-glucose PET to locate parathyroid adenomas in primary hyperparathyroidism. Radiology 1994;192:280.PubMed
26.
Zurück zum Zitat Melon P, Luxen A, Hamoir E, Meurisse M. Fluorine-18-fluorodeoxyglucose positron emission tomography for preoperative parathyroid imaging in primary hyperparathyroidism. Eur J Nucl Med 1995;22:556–8.PubMed Melon P, Luxen A, Hamoir E, Meurisse M. Fluorine-18-fluorodeoxyglucose positron emission tomography for preoperative parathyroid imaging in primary hyperparathyroidism. Eur J Nucl Med 1995;22:556–8.PubMed
27.
Zurück zum Zitat Neumann DR, Esselstyn CB, MacIntyre WJ, Go RT, Obuchowski NA, Chen EQ, et al. Comparison of FDG-PET and sestamibi-SPECT in primary hyperparathyroidism. J Nucl Med 1996;37:1809–15.PubMed Neumann DR, Esselstyn CB, MacIntyre WJ, Go RT, Obuchowski NA, Chen EQ, et al. Comparison of FDG-PET and sestamibi-SPECT in primary hyperparathyroidism. J Nucl Med 1996;37:1809–15.PubMed
28.
Zurück zum Zitat Cook GJ, Wong JC, Smellie WJ, Young AE, Maisey MN, Fogelman I. [11C]Methionine positron emission tomography for patients with persistent or recurrent hyperparathyroidism after surgery. Eur J Endocrinol 1998;139:195–7. doi:10.1530/eje.0.1390195.PubMedCrossRef Cook GJ, Wong JC, Smellie WJ, Young AE, Maisey MN, Fogelman I. [11C]Methionine positron emission tomography for patients with persistent or recurrent hyperparathyroidism after surgery. Eur J Endocrinol 1998;139:195–7. doi:10.​1530/​eje.​0.​1390195.PubMedCrossRef
29.
Zurück zum Zitat Rubello D, Fanti S, Nanni C, Farsad M, Castellucci P, Boschi S, et al. 11C-methionine PET/CT in 99mTc-sestamibi-negative hyperparathyroidism in patients with renal failure on chronic haemodialysis. Eur J Nucl Med Mol Imaging 2006;33(4):453–9. doi:10.1007/s00259-005-0008-z.PubMedCrossRef Rubello D, Fanti S, Nanni C, Farsad M, Castellucci P, Boschi S, et al. 11C-methionine PET/CT in 99mTc-sestamibi-negative hyperparathyroidism in patients with renal failure on chronic haemodialysis. Eur J Nucl Med Mol Imaging 2006;33(4):453–9. doi:10.​1007/​s00259-005-0008-z.PubMedCrossRef
30.
Zurück zum Zitat Hessman O, Stålberg P, Sundin A, Garske U, Rudberg C, Eriksson LG, et al. High success rate of parathyroid reoperation may be achieved with improved localization diagnosis. World J Surg 2008;32(5):774–81. doi:10.1007/s00268-008-9537-5. discussion 782–3.PubMedCrossRef Hessman O, Stålberg P, Sundin A, Garske U, Rudberg C, Eriksson LG, et al. High success rate of parathyroid reoperation may be achieved with improved localization diagnosis. World J Surg 2008;32(5):774–81. doi:10.​1007/​s00268-008-9537-5. discussion 782–3.PubMedCrossRef
31.
Zurück zum Zitat Stabin MG. Health concerns related to radiation exposure of the female nuclear medicine patient. Environ Health Perspect 1997;105(Suppl 6):1403–9.PubMedCrossRef Stabin MG. Health concerns related to radiation exposure of the female nuclear medicine patient. Environ Health Perspect 1997;105(Suppl 6):1403–9.PubMedCrossRef
33.
Zurück zum Zitat Hindié E, Melliere D, Simon D, Perlemuter L, Galle P. Primary hyperparathyroidism: is technetium 99m-sestamibi/iodine-123 subtraction scanning the best procedure to locate enlarged glands before surgery? J Clin Endocrinol Metab 1995;80(1):302–7. doi:10.1210/jc.80.1.302.PubMedCrossRef Hindié E, Melliere D, Simon D, Perlemuter L, Galle P. Primary hyperparathyroidism: is technetium 99m-sestamibi/iodine-123 subtraction scanning the best procedure to locate enlarged glands before surgery? J Clin Endocrinol Metab 1995;80(1):302–7. doi:10.​1210/​jc.​80.​1.​302.PubMedCrossRef
35.
Zurück zum Zitat Hindié E, Mellière D, Jeanguillaume C, Chéhadé F, Galle P. Acquisition double-fenêtre 99mTc-MIBI/123I vs 99mTc-MIBI seul dans l’hyperparathyroïdie primitive. Oral communication, XXXVe Colloque de Médecine Nucléaire, Lille, 15–18 October 1996. Hindié E, Mellière D, Jeanguillaume C, Chéhadé F, Galle P. Acquisition double-fenêtre 99mTc-MIBI/123I vs 99mTc-MIBI seul dans l’hyperparathyroïdie primitive. Oral communication, XXXVe Colloque de Médecine Nucléaire, Lille, 15–18 October 1996.
36.
Zurück zum Zitat Hindié E, Mellière D, Jeanguillaume C, Perlemuter L, Chéhadé F, Galle P. Parathyroid imaging using simultaneous double-window recording of technetium-99m-sestamibi and iodine-123. J Nucl Med 1998;39:1100–5.PubMed Hindié E, Mellière D, Jeanguillaume C, Perlemuter L, Chéhadé F, Galle P. Parathyroid imaging using simultaneous double-window recording of technetium-99m-sestamibi and iodine-123. J Nucl Med 1998;39:1100–5.PubMed
37.
Zurück zum Zitat Weber CJ, Vansant J, Alazraki N, Christy J, Watts N, Phillips LS, et al. Value of technetium 99m sestamibi iodine 123 imaging in reoperative parathyroid surgery. Surgery 1993;114:1011–8.PubMed Weber CJ, Vansant J, Alazraki N, Christy J, Watts N, Phillips LS, et al. Value of technetium 99m sestamibi iodine 123 imaging in reoperative parathyroid surgery. Surgery 1993;114:1011–8.PubMed
38.
Zurück zum Zitat Hindié E, Mellière D, Perlemuter L, Jeanguillaume C, Galle P. Primary hyperparathyroidism: higher success rate of first surgery after preoperative Tc-99m sestamibi-I-123 subtraction scanning. Radiology 1997;204:221–8.PubMed Hindié E, Mellière D, Perlemuter L, Jeanguillaume C, Galle P. Primary hyperparathyroidism: higher success rate of first surgery after preoperative Tc-99m sestamibi-I-123 subtraction scanning. Radiology 1997;204:221–8.PubMed
39.
Zurück zum Zitat Rubello D, Pelizzo MR, Casara D. Nuclear medicine and minimally invasive surgery of parathyroid adenomas: a fair marriage. Eur J Nucl Med Mol Imaging 2003;30:189–92.PubMed Rubello D, Pelizzo MR, Casara D. Nuclear medicine and minimally invasive surgery of parathyroid adenomas: a fair marriage. Eur J Nucl Med Mol Imaging 2003;30:189–92.PubMed
40.
41.
Zurück zum Zitat Johnston LB, Carroll MJ, Britton KE, Lowe DG, Shand W, Besser GM, et al. The accuracy of parathyroid gland localization in primary hyperparathyroidism using sestamibi radionuclide imaging. J Clin Endocrinol Metab 1996;81(1):346–52. doi:10.1210/jc.81.1.346.PubMedCrossRef Johnston LB, Carroll MJ, Britton KE, Lowe DG, Shand W, Besser GM, et al. The accuracy of parathyroid gland localization in primary hyperparathyroidism using sestamibi radionuclide imaging. J Clin Endocrinol Metab 1996;81(1):346–52. doi:10.​1210/​jc.​81.​1.​346.PubMedCrossRef
42.
Zurück zum Zitat Hindié E, Mellière D, Jeanguillaume C, Ureña P, deLabriolle-Vaylet C, Perlemuter L. Unilateral surgery for primary hyperparathyroidism on the basis of technetium Tc 99m sestamibi and iodine 123 subtraction scanning. Arch Surg 2000;135:1461–8. doi:10.1001/archsurg.135.12.1461.PubMedCrossRef Hindié E, Mellière D, Jeanguillaume C, Ureña P, deLabriolle-Vaylet C, Perlemuter L. Unilateral surgery for primary hyperparathyroidism on the basis of technetium Tc 99m sestamibi and iodine 123 subtraction scanning. Arch Surg 2000;135:1461–8. doi:10.​1001/​archsurg.​135.​12.​1461.PubMedCrossRef
43.
Zurück zum Zitat Taillefer R, Boucher Y, Potvin C, Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study). J Nucl Med 1992;33:1801–7.PubMed Taillefer R, Boucher Y, Potvin C, Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study). J Nucl Med 1992;33:1801–7.PubMed
45.
Zurück zum Zitat Haber RS, Kim CK, Inabnet WB. Ultrasonography for preoperative localization of enlarged parathyroid glands in primary hyperparathyroidism: comparison with (99m) technetium sestamibi scintigraphy. Clin Endocrinol (Oxf) 2002;57:241–9. doi:10.1046/j.1365-2265.2002.01583.x.CrossRef Haber RS, Kim CK, Inabnet WB. Ultrasonography for preoperative localization of enlarged parathyroid glands in primary hyperparathyroidism: comparison with (99m) technetium sestamibi scintigraphy. Clin Endocrinol (Oxf) 2002;57:241–9. doi:10.​1046/​j.​1365-2265.​2002.​01583.​x.CrossRef
46.
Zurück zum Zitat Chesser AM, Carroll MC, Lightowler C, Macdougall IC, Britton KE, Baker LR. Technetium-99m methoxy isobutyl isonitrile (MIBI) imaging of the parathyroid glands in patients with renal failure. Nephrol Dial Transplant 1997;12(1):97–100. doi:10.1093/ndt/12.1.97.PubMedCrossRef Chesser AM, Carroll MC, Lightowler C, Macdougall IC, Britton KE, Baker LR. Technetium-99m methoxy isobutyl isonitrile (MIBI) imaging of the parathyroid glands in patients with renal failure. Nephrol Dial Transplant 1997;12(1):97–100. doi:10.​1093/​ndt/​12.​1.​97.PubMedCrossRef
47.
Zurück zum Zitat Jeanguillaume C, Ureña P, Hindié E, Prieur P, Pétrover M, Menoyo-Calonge V, et al. Secondary hyperparathyroidism: detection with I-123-Tc-99m-sestamibi subtraction scintigraphy versus US. Radiology 1998;207(1):207–13.PubMed Jeanguillaume C, Ureña P, Hindié E, Prieur P, Pétrover M, Menoyo-Calonge V, et al. Secondary hyperparathyroidism: detection with I-123-Tc-99m-sestamibi subtraction scintigraphy versus US. Radiology 1998;207(1):207–13.PubMed
48.
Zurück zum Zitat Hindié E, Ureña P, Jeanguillaume C, Mellière D, Berthelot JM, Manoyo-Calonge V, et al. Preoperative imaging of parathyroid glands with technetium-99m-labelled sestamibi and iodine-123 subtraction scanning in secondary hyperparathyroidism. Lancet 1999;353:2200–4. doi:10.1016/S0140-6736(98)09089-8.PubMedCrossRef Hindié E, Ureña P, Jeanguillaume C, Mellière D, Berthelot JM, Manoyo-Calonge V, et al. Preoperative imaging of parathyroid glands with technetium-99m-labelled sestamibi and iodine-123 subtraction scanning in secondary hyperparathyroidism. Lancet 1999;353:2200–4. doi:10.​1016/​S0140-6736(98)09089-8.PubMedCrossRef
49.
Zurück zum Zitat Neumann DR, Esselstyn CB Jr, Madera A, Wong CO, Lieber M. Parathyroid detection in secondary hyperparathyroidism with 123I/99mTc-sestamibi subtraction single photon emission computed tomography. J Clin Endocrinol Metab 1998;83(11):3867–71. doi:10.1210/jc.83.11.3867.PubMedCrossRef Neumann DR, Esselstyn CB Jr, Madera A, Wong CO, Lieber M. Parathyroid detection in secondary hyperparathyroidism with 123I/99mTc-sestamibi subtraction single photon emission computed tomography. J Clin Endocrinol Metab 1998;83(11):3867–71. doi:10.​1210/​jc.​83.​11.​3867.PubMedCrossRef
50.
Zurück zum Zitat Akerström G, Malmaeus J, Bergström R. Surgical anatomy of human parathyroid glands. Surgery 1984;95:14–21.PubMed Akerström G, Malmaeus J, Bergström R. Surgical anatomy of human parathyroid glands. Surgery 1984;95:14–21.PubMed
52.
Zurück zum Zitat Taïeb D, Hassad R, Sebag F, Colavolpe C, Guedj E, Hindié E, et al. Tomoscintigraphy improves the determination of the embryologic origin of parathyroid adenomas, especially in apparently inferior glands: imaging features and surgical implications. J Nucl Med Technol 2007;35(3):135–9. doi:10.2967/jnmt.107.039743.PubMedCrossRef Taïeb D, Hassad R, Sebag F, Colavolpe C, Guedj E, Hindié E, et al. Tomoscintigraphy improves the determination of the embryologic origin of parathyroid adenomas, especially in apparently inferior glands: imaging features and surgical implications. J Nucl Med Technol 2007;35(3):135–9. doi:10.​2967/​jnmt.​107.​039743.PubMedCrossRef
53.
54.
Zurück zum Zitat Geatti O, Shapiro B, Orsolon PG, Proto G, Guerra UP, Antonucci F, et al. Localization of parathyroid enlargement: experience with technetium-99m methoxyisobutylisonitrile and thallium-201 scintigraphy, ultrasonography and computed tomography. Eur J Nucl Med 1994;21(1):17–22. doi:10.1007/BF00182301.PubMedCrossRef Geatti O, Shapiro B, Orsolon PG, Proto G, Guerra UP, Antonucci F, et al. Localization of parathyroid enlargement: experience with technetium-99m methoxyisobutylisonitrile and thallium-201 scintigraphy, ultrasonography and computed tomography. Eur J Nucl Med 1994;21(1):17–22. doi:10.​1007/​BF00182301.PubMedCrossRef
55.
Zurück zum Zitat Casara D, Rubello D, Saladini G, Piotto A, Toniato A, Pellizzo MR. Imaging procedures in evaluation of hyperparathyroidism: the role of scintigraphy with 99mTc-MIBI. In: Ravelli E, Samori G, editors. Primary and secondary hyperparathyroidism. Milan: Wichtig Ed; 1992. p. 133–6. Casara D, Rubello D, Saladini G, Piotto A, Toniato A, Pellizzo MR. Imaging procedures in evaluation of hyperparathyroidism: the role of scintigraphy with 99mTc-MIBI. In: Ravelli E, Samori G, editors. Primary and secondary hyperparathyroidism. Milan: Wichtig Ed; 1992. p. 133–6.
57.
Zurück zum Zitat Greenspan BS, Brown ML, Dillehay GL, McBiles M, Sandler MP, Seabold JE, et al. Procedure guideline for parathyroid scintigraphy. Society of Nuclear Medicine. J Nucl Med 1998;39(6):1111–4.PubMed Greenspan BS, Brown ML, Dillehay GL, McBiles M, Sandler MP, Seabold JE, et al. Procedure guideline for parathyroid scintigraphy. Society of Nuclear Medicine. J Nucl Med 1998;39(6):1111–4.PubMed
58.
Zurück zum Zitat Fuster D, Ybarra J, Ortiz J, Torregrosa JV, Gilabert R, Setoain X, et al. Role of pre-operative imaging using 99mTc-MIBI and neck ultrasound in patients with secondary hyperparathyroidism who are candidates for subtotal parathyroidectomy. Eur J Nucl Med Mol Imaging 2006;33:467–73. doi:10.1007/s00259-005-0021-2.PubMedCrossRef Fuster D, Ybarra J, Ortiz J, Torregrosa JV, Gilabert R, Setoain X, et al. Role of pre-operative imaging using 99mTc-MIBI and neck ultrasound in patients with secondary hyperparathyroidism who are candidates for subtotal parathyroidectomy. Eur J Nucl Med Mol Imaging 2006;33:467–73. doi:10.​1007/​s00259-005-0021-2.PubMedCrossRef
59.
Zurück zum Zitat Aigner RM, Fueger GF, Nicoletti R. Parathyroid scintigraphy: comparison of technetium-99m methoxyisobutylisonitrile and technetium-99m tetrofosmin studies. Eur J Nucl Med 1996;23:693–6. doi:10.1007/BF00834533.PubMedCrossRef Aigner RM, Fueger GF, Nicoletti R. Parathyroid scintigraphy: comparison of technetium-99m methoxyisobutylisonitrile and technetium-99m tetrofosmin studies. Eur J Nucl Med 1996;23:693–6. doi:10.​1007/​BF00834533.PubMedCrossRef
60.
Zurück zum Zitat Lorberboym M, Minski I, Macadziob S, Nikolov G, Schachter P. Incremental diagnostic value of preoperative 99mTc-MIBI SPECT in patients with a parathyroid adenoma. J Nucl Med 2003;44:904–8.PubMed Lorberboym M, Minski I, Macadziob S, Nikolov G, Schachter P. Incremental diagnostic value of preoperative 99mTc-MIBI SPECT in patients with a parathyroid adenoma. J Nucl Med 2003;44:904–8.PubMed
61.
Zurück zum Zitat Perez-Monte JE, Brown ML, Shah AN, Ranger NT, Watson CG, Carty SE, et al. Parathyroid adenomas: accurate detection and localization with Tc-99m sestamibi SPECT. Radiology 1996;201:85–91.PubMed Perez-Monte JE, Brown ML, Shah AN, Ranger NT, Watson CG, Carty SE, et al. Parathyroid adenomas: accurate detection and localization with Tc-99m sestamibi SPECT. Radiology 1996;201:85–91.PubMed
62.
Zurück zum Zitat Billotey C, Sarfati E, Aurengo A, Duet M, Mündler O, Toubert ME, et al. Advantages of SPECT in technetium-99m-sestamibi parathyroid scintigraphy. J Nucl Med 1996;37:1773–8.PubMed Billotey C, Sarfati E, Aurengo A, Duet M, Mündler O, Toubert ME, et al. Advantages of SPECT in technetium-99m-sestamibi parathyroid scintigraphy. J Nucl Med 1996;37:1773–8.PubMed
63.
Zurück zum Zitat Piga M, Serra A, Uccheddu A, Letizia Lai M, Faa G. Decisive presurgical role of MIBI SPECT/CT in identifying within a calcific thyroid nodule the parathyroid responsible for primary hyperparathyroidism. Surgery 2006;140(5):837–8. doi:10.1016/j.surg.2006.04.009.PubMedCrossRef Piga M, Serra A, Uccheddu A, Letizia Lai M, Faa G. Decisive presurgical role of MIBI SPECT/CT in identifying within a calcific thyroid nodule the parathyroid responsible for primary hyperparathyroidism. Surgery 2006;140(5):837–8. doi:10.​1016/​j.​surg.​2006.​04.​009.PubMedCrossRef
64.
Zurück zum Zitat Spanu A, Falchi A, Manca A, Marongiu P, Cossu A, Pisu N, et al. The usefulness of neck pinhole SPECT as a complementary tool to planar scintigraphy in primary and secondary hyperparathyroidism. J Nucl Med 2004;45:40–8.PubMed Spanu A, Falchi A, Manca A, Marongiu P, Cossu A, Pisu N, et al. The usefulness of neck pinhole SPECT as a complementary tool to planar scintigraphy in primary and secondary hyperparathyroidism. J Nucl Med 2004;45:40–8.PubMed
65.
Zurück zum Zitat Carlier T, Oudoux A, Mirallié E, Seret A, Daumy I, Leux C, et al. 99mTc-MIBI pinhole SPECT in primary hyperparathyroidism: comparison with conventional SPECT, planar scintigraphy and ultrasonography. Eur J Nucl Med Mol Imaging 2008;35:637–43. doi:10.1007/s00259-007-0625-9.PubMedCrossRef Carlier T, Oudoux A, Mirallié E, Seret A, Daumy I, Leux C, et al. 99mTc-MIBI pinhole SPECT in primary hyperparathyroidism: comparison with conventional SPECT, planar scintigraphy and ultrasonography. Eur J Nucl Med Mol Imaging 2008;35:637–43. doi:10.​1007/​s00259-007-0625-9.PubMedCrossRef
66.
Zurück zum Zitat AACE/AAES Task Force on Primary Hyperparathyroidism. The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism. Endocr Pract 2005;11:49–54. AACE/AAES Task Force on Primary Hyperparathyroidism. The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism. Endocr Pract 2005;11:49–54.
67.
Zurück zum Zitat Gulec SA, Uğur O. The intellectual and scientific basis of parathyroid surgery. Turk J Med Sci 2004;34:81–4. Gulec SA, Uğur O. The intellectual and scientific basis of parathyroid surgery. Turk J Med Sci 2004;34:81–4.
68.
Zurück zum Zitat Mandl F. Therapeutic attempt of osteitis fibrosa generalisata by excision of an epithelial-corpuscle tumors. Wien Klin Wochenschr 1925;195:1343–4. Mandl F. Therapeutic attempt of osteitis fibrosa generalisata by excision of an epithelial-corpuscle tumors. Wien Klin Wochenschr 1925;195:1343–4.
69.
Zurück zum Zitat NIH conference. diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement. Ann Intern Med 1991;114:593–7. NIH conference. diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement. Ann Intern Med 1991;114:593–7.
70.
Zurück zum Zitat Rudberg C, Akerström G, Palmér M, Ljunghall S, Adami HO, Johansson H, et al. Late results of operation for primary hyperparathyroidism in 441 patients. Surgery 1986;99:643–51.PubMed Rudberg C, Akerström G, Palmér M, Ljunghall S, Adami HO, Johansson H, et al. Late results of operation for primary hyperparathyroidism in 441 patients. Surgery 1986;99:643–51.PubMed
72.
Zurück zum Zitat Norman JG. Minimally invasive radioguided parathyroidectomy: an endocrine surgeon’s perspective. J Nucl Med 1998;39:15N–24N.PubMed Norman JG. Minimally invasive radioguided parathyroidectomy: an endocrine surgeon’s perspective. J Nucl Med 1998;39:15N–24N.PubMed
74.
Zurück zum Zitat Saaristo RA, Salmi JJ, Kööbi T, Turjanmaa V, Sand JA, Nordback IH. Intraoperative localization of parathyroid glands with gamma counter probe in primary hyperparathyroidism: a prospective study. J Am Coll Surg 2002;195:19–22. doi:10.1016/S1072-7515(02)01178-X.PubMedCrossRef Saaristo RA, Salmi JJ, Kööbi T, Turjanmaa V, Sand JA, Nordback IH. Intraoperative localization of parathyroid glands with gamma counter probe in primary hyperparathyroidism: a prospective study. J Am Coll Surg 2002;195:19–22. doi:10.​1016/​S1072-7515(02)01178-X.PubMedCrossRef
78.
Zurück zum Zitat Rubello D, Casara D, Shapiro B. Recent advances in preoperative and intraoperative nuclear medicine procedures in patients with primary hyperparathyroidism. Panminerva Med 2002;44:99–105.PubMed Rubello D, Casara D, Shapiro B. Recent advances in preoperative and intraoperative nuclear medicine procedures in patients with primary hyperparathyroidism. Panminerva Med 2002;44:99–105.PubMed
79.
Zurück zum Zitat Ugur O, Bozkurt MF, Rubello D. Nuclear medicine techniques for radio-guided surgery of hyperparathyroidism. Minerva Endocrinol 2008;33:95–104.PubMed Ugur O, Bozkurt MF, Rubello D. Nuclear medicine techniques for radio-guided surgery of hyperparathyroidism. Minerva Endocrinol 2008;33:95–104.PubMed
81.
Zurück zum Zitat Casara D, Rubello D, Piotto A, Pelizzo MR. Tc99m-MIBI radio-guided minimally invasive parathyroid surgery planned on the basis of a preoperative combined 99mTc-pertechnetate/99mTc-MIBI and ultrasound imaging protocol. Eur J Nucl Med 2000;27:1300–4. doi:10.1007/s002590000297.PubMedCrossRef Casara D, Rubello D, Piotto A, Pelizzo MR. Tc99m-MIBI radio-guided minimally invasive parathyroid surgery planned on the basis of a preoperative combined 99mTc-pertechnetate/99mTc-MIBI and ultrasound imaging protocol. Eur J Nucl Med 2000;27:1300–4. doi:10.​1007/​s002590000297.PubMedCrossRef
83.
Zurück zum Zitat Murphy C, Norman J. The 20% rule: a simple, instantaneous radioactivity measurement defines cure and allows elimination of frozen sections and hormone assays during parathyroidectomy. Surgery 1999;126:1023–9. doi:10.1067/msy.2099.101578.PubMedCrossRef Murphy C, Norman J. The 20% rule: a simple, instantaneous radioactivity measurement defines cure and allows elimination of frozen sections and hormone assays during parathyroidectomy. Surgery 1999;126:1023–9. doi:10.​1067/​msy.​2099.​101578.PubMedCrossRef
84.
Zurück zum Zitat Ugur O, Kara PO, Bozkurt MF, Hamaloglu E, Tezel GG, Salanci BV, et al. In vivo characterisation of parathyroid lesions by use of gamma probe: comparison with ex vivo count method and frozen section results. Otolaryngol Head Neck Surg 2006;134:316–20. doi:10.1016/j.otohns.2005.08.010.PubMedCrossRef Ugur O, Kara PO, Bozkurt MF, Hamaloglu E, Tezel GG, Salanci BV, et al. In vivo characterisation of parathyroid lesions by use of gamma probe: comparison with ex vivo count method and frozen section results. Otolaryngol Head Neck Surg 2006;134:316–20. doi:10.​1016/​j.​otohns.​2005.​08.​010.PubMedCrossRef
86.
Zurück zum Zitat Rubello D, Piotto A, Casara D, Muzzio PC, Shapiro B, Pelizzo MR. Role of gamma probes in performing minimally invasive parathyroidectomy in patients with primary hyperparathyroidism: Optimization of preoperative and intraoperative procedures. Eur J Endocrinol 2003;149:7–15. doi:10.1530/eje.0.1490007.PubMedCrossRef Rubello D, Piotto A, Casara D, Muzzio PC, Shapiro B, Pelizzo MR. Role of gamma probes in performing minimally invasive parathyroidectomy in patients with primary hyperparathyroidism: Optimization of preoperative and intraoperative procedures. Eur J Endocrinol 2003;149:7–15. doi:10.​1530/​eje.​0.​1490007.PubMedCrossRef
87.
Zurück zum Zitat Gough J, Anliker M, Spieth ME, Kasner DL. Parathyroid adenoma radiation dose simulator. Clin Med Res 2004;2:55–8.PubMedCrossRef Gough J, Anliker M, Spieth ME, Kasner DL. Parathyroid adenoma radiation dose simulator. Clin Med Res 2004;2:55–8.PubMedCrossRef
89.
Zurück zum Zitat Lundgren E, Rastad J, Thurfjell E, Akerström G, Ljunghall S. Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery 1997;121:287–94. doi:10.1016/S0039-6060(97)90357-3.PubMedCrossRef Lundgren E, Rastad J, Thurfjell E, Akerström G, Ljunghall S. Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery 1997;121:287–94. doi:10.​1016/​S0039-6060(97)90357-3.PubMedCrossRef
90.
Zurück zum Zitat Marx SJ, Simonds WF, Agarwal SK, Burns AL, Weinstein LS, Cochran C, et al. Hyperparathyroidism in hereditary syndromes: special expressions and special managements. J Bone Miner Res 2002;17(Suppl 2):N37–43.PubMed Marx SJ, Simonds WF, Agarwal SK, Burns AL, Weinstein LS, Cochran C, et al. Hyperparathyroidism in hereditary syndromes: special expressions and special managements. J Bone Miner Res 2002;17(Suppl 2):N37–43.PubMed
91.
Zurück zum Zitat Levin KE, Clark OH. The reasons for failure in parathyroid operations. Arch Surg 1989;124:911–5.PubMed Levin KE, Clark OH. The reasons for failure in parathyroid operations. Arch Surg 1989;124:911–5.PubMed
92.
93.
Zurück zum Zitat Baliski C, Nosyk B, Melck A, Bugis S, Rosenberg F, Anis AH. The cost-effectiveness of three strategies for the surgical treatment of symptomatic primary hyperparathyroidism. Ann Surg Oncol 2008;15(10):2653–60. doi:10.1245/s10434-008-0066-0.PubMedCrossRef Baliski C, Nosyk B, Melck A, Bugis S, Rosenberg F, Anis AH. The cost-effectiveness of three strategies for the surgical treatment of symptomatic primary hyperparathyroidism. Ann Surg Oncol 2008;15(10):2653–60. doi:10.​1245/​s10434-008-0066-0.PubMedCrossRef
94.
Zurück zum Zitat Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2008;52(3):519–30. doi:10.1053/j.ajkd.2008.03.020.PubMedCrossRef Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2008;52(3):519–30. doi:10.​1053/​j.​ajkd.​2008.​03.​020.PubMedCrossRef
Metadaten
Titel
2009 EANM parathyroid guidelines
verfasst von
Elif Hindié
Ömer Ugur
David Fuster
Michael ODoherty
Gaia Grassetto
Pablo Ureña
Andrew Kettle
Seza A. Gulec
Francesca Pons
Domenico Rubello
Publikationsdatum
01.07.2009
Verlag
Springer-Verlag
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 7/2009
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-009-1131-z

Weitere Artikel der Ausgabe 7/2009

European Journal of Nuclear Medicine and Molecular Imaging 7/2009 Zur Ausgabe